Stock listing

Immunovia Ab

Selected listing: IMMNOV · OMXSTO · SEK · SE

Immunovia Ab (Stockholm:IMMNOV), Health Technology. Latest release Aug 6, 2026: Immunovia Publishes Interim Report for April-June 2026.

IMMNOV:OMXSTOSEKSEUpdated October 3, 2026

Ticker: Stockholm:IMMNOV
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Stockholm
Currency: SEK

About Immunovia Ab

Immunovia Ab is a public company listed on the Swedish market under the ticker IMMNOV. Immunovia focuses on developing innovative diagnostic solutions for cancer, leveraging advanced technology to improve patient outcomes.

Latest news from Immunovia Ab

Immunovia Publishes Interim Report for April-June 2026

August 6, 2026

Immunovia announces new performance data for PancreaSure ahead of upcoming application for Medicare coverage

June 15, 2026

Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure

June 10, 2026

Immunovia Publishes Interim Report for January-March 2026

May 7, 2026

Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance

May 5, 2026

All Immunovia Ab news →

Events

Replays

Immunovia AB (IMMNOV) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 09:00 AM ET
Watch
Immunovia AB (IMMNOV) Q1 2026 Earnings Call
Thu, May 07, 2026 · 09:00 AM ET
Watch
Immunovia AB (IMMNOV) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 09:00 AM ET
Watch

Research Immunovia Ab

Immunovia Ab company profile

View the public company page for Immunovia Ab on 6ix.

Immunovia Ab news

Read company news and market updates connected to Immunovia Ab.

Immunovia Ab investor events

Find investor webinars, events, and replay context for Immunovia Ab.